FDA is departing from long-standing procedures to deal with public health crises, and this may foreshadow problems for COVID-19 vaccines
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Yaniv Heled, Associate Professor of Law, Georgia State University •
conversation
Aug. 27, 2020 • ~10 min
Aug. 27, 2020 • ~10 min
I'm a lung doctor testing the blood plasma from COVID-19 survivors as a treatment for the sick – a century-old idea that could be a fast track to treatment
In the blood of COVID-19 survivors are antibodies that can defeat SARS-CoV-2. Researchers are testing whether these antibodies can be collected and injected into others to save them from the virus.
Jeffrey M. Sturek, Assistant Professor of Medicine, University of Virginia
• conversation
Aug. 21, 2020 • ~8 min
Aug. 21, 2020 • ~8 min
I'm a lung doctor testing the blood from COVID-19 survivors as a treatment for the sick – a century old idea that could be a fast track to treatment
In the blood of COVID-19 survivors are antibodies that can defeat SARS-CoV-2. Researchers are testing whether these antibodies can be collected and injected into others to save them from the virus.
Jeffrey M. Sturek, Assistant Professor of Medicine, University of Virginia
• conversation
Aug. 21, 2020 • ~7 min
Aug. 21, 2020 • ~7 min
Seven things you might not know about blood
We're full of blood – around five litres, on average.
Adam Taylor, Professor and Director of the Clinical Anatomy Learning Centre, Lancaster University
• conversation
May 13, 2020 • ~7 min
May 13, 2020 • ~7 min
/
16